Table 4. Changes in clinical and psychosocial variables that predict change in psychosocial and functional quality of life.
| β | t | P |
95% CI for β |
||
|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||
| Outcome: psychosocial quality of life (constant) | 0.00 | 0.39 | 0.69 | −0.08 | 0.12 |
| Success | |||||
| Partial success | −0.03 | −0.78 | 0.44 | −0.22 | 0.09 |
| Unsuccessful | 0.00 | −0.13 | 0.90 | −0.27 | 0.24 |
| Change in IPQ-R timeline | 0.00 | 0.04 | 0.97 | −0.08 | 0.08 |
| Change in IPQ-R consequences | −0.16 | −3.09 | 0.00 | −0.26 | −0.06 |
| Change in IPQ-R personal control | −0.01 | −0.15 | 0.88 | −0.08 | 0.07 |
| Change in TRI treatment value | 0.02 | 0.48 | 0.63 | −0.07 | 0.12 |
| Change in TRI treatment concerns | −0.03 | −0.78 | 0.43 | −0.11 | 0.05 |
| Change in TRI decision satisfaction | −0.02 | −0.40 | 0.69 | −0.10 | 0.07 |
| Change in TRI cure | −0.04 | −0.77 | 0.44 | −0.14 | 0.06 |
| Change in FNE | −0.04 | −0.85 | 0.39 | −0.14 | 0.06 |
| Change in salience | −0.11 | −2.33 | 0.02 | −0.20 | −0.02 |
| Change in DAS24 | −0.31 | −5.42 | 0.00 | −0.41 | −0.19 |
| Change in valence | −0.05 | −0.93 | 0.35 | −0.14 | 0.05 |
| Change in perceived visibility | −0.42 | −8.68 | 0.00 | −0.51 | −0.32 |
| Change in social support—significant others | 0.07 | 1.53 | 0.13 | −0.02 | 0.16 |
| Change in social support—family | −0.06 | −1.20 | 0.23 | −0.16 | 0.04 |
| Change in social support—friends | 0.02 | 0.38 | 0.70 | −0.07 | 0.11 |
| Change in anxiety | −0.06 | −1.13 | 0.26 | −0.16 | 0.04 |
| Change in depression | 0.04 | 0.73 | 0.47 | −0.07 | 0.14 |
| Outcome: functional quality of life (constant) | 0.00 | −0.36 | 0.72 | −0.17 | 0.12 |
| Success | |||||
| Partial success | 0.01 | 0.22 | 0.83 | −0.21 | 0.26 |
| Unsuccessful | 0.00 | 0.01 | 0.99 | −0.36 | 0.36 |
| Change in IPQ-R timeline | 0.01 | 0.15 | 0.88 | −0.11 | 0.13 |
| Change in IPQ-R consequences | −0.38 | −4.83 | 0.00 | −0.51 | −0.22 |
| Change in IPQ-R personal control | 0.06 | 1.06 | 0.29 | −0.05 | 0.16 |
| Change in TRI treatment value | −0.09 | −1.20 | 0.23 | −0.22 | 0.05 |
| Change in TRI treatment concerns | −0.12 | −1.97 | 0.05 | −0.24 | 0.00 |
| Change in TRI decision satisfaction | −0.06 | −0.94 | 0.35 | −0.19 | 0.07 |
| Change in TRI cure | 0.05 | 0.64 | 0.52 | −0.10 | 0.19 |
| Change in FNE | 0.02 | 0.29 | 0.77 | −0.12 | 0.16 |
| Change in DAS24 | −0.07 | −0.82 | 0.41 | −0.22 | 0.09 |
| Change in salience | 0.01 | 0.08 | 0.94 | −0.13 | 0.14 |
| Change in valence | −0.02 | −0.26 | 0.79 | −0.16 | 0.12 |
| Change in perceived visibility | 0.23 | 3.28 | 0.00 | 0.09 | 0.36 |
| Change in social support—significant others | −0.13 | −2.07 | 0.04 | −0.26 | −0.01 |
| Change in social support—family | −0.02 | −0.29 | 0.77 | −0.16 | 0.12 |
| Change in social support—friends | 0.09 | 1.30 | 0.19 | −0.04 | 0.22 |
| Change in anxiety | −0.05 | −0.60 | 0.55 | −0.19 | 0.10 |
| Change in depression | −0.34 | −4.39 | 0.00 | −0.49 | −0.19 |
Bold values are statistically significant (P<0.05).